Form4insider filings, from the source

SEC Form 4 · accession 0001654954-18-002935

CorMedix Inc. · CRMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Myron Kaplan
Director
Period of report
Feb 21, 2018
Accepted (ET)
Mar 22, 2018 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 21, 2018M10,000$0.00A294,166D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF1$0.00Feb 21, 2018M10,000D——Common Stock10,0000D
Stock Option (Right to Buy Common Stock)F2$0.57holding————Feb 16, 2028Common Stock40,00040,000D
Restricted Stock UnitsF3—holding—————Common Stock10,00010,000D
Restricted Stock UnitsF3—holding—————Common Stock12,00012,000D
Restricted Stock UnitsF4—holding—————Common Stock5,0005,000D
Stock Option (Right to Buy Common Stock)F5$2.24holding—————Common Stock40,00040,000D
Stock Option (Right to Buy Common Stock)F6$4.28holding————Apr 28, 2026Common Stock50,00050,000D

Explanation of responses